A couple even danced while holding walkers
In the LEADER trial (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results), researchers found that liraglutide reduced the risk of cardiovascular events in diabetic patients, including heart attack, stroke, and cardiovascular death, by 13% compared to placebo
En promedio, entre un 15% y un 20% del peso inicial despus de un ao, aunque vara segn el paciente
Lauren Papanos, MS, RD, CSSD, is a nationally recognized Registered Dietitian Nutritionist, board-certified sports dietitian, published researcher, and founder of Functional Fueling Nutrition, an award winning endocrinology nutrition practice specializing in thyroid health, metabolism, fertility, and hormones
Lillys Mounjaro back in stock amid heightened obesity interest